Supporting Information Text Blood Specimens
Blood samples were drawn from homozygous SS sickle cell disease patients at the University of Pittsburgh, Pittsburgh, PA (University of Pittsburgh IRB protocol PRO08110422) and the Massachusetts General Hospital, Boston, MA under a protocol of Excess Human Materials approved by the Partners Healthcare IRB with a waiver of consent. On-hydroxyurea treatment and off-hydroxyurea treatment patient samples were used. Sample specimens used for this study were restricted to patients that were not in crisis and patients with transfusions 30 days prior to blood draw. Blood was collected in 4 ml K2 ethylenediaminetetraacetic acid (EDTA) spray-coated anticoagulant vacutainers (1.8 mg/ml). Sample vacutainers were shipped to MIT on melting ice by overnight delivery and stored at 4°C. Hemoglobin fractions were determined with cellulose agar electrophoresis and confirmed by high performance liquid chromatography. Density gradient centrifugation of the anticoagulated blood was performed at 820 × g for 5 minutes. The buffy coat and blood plasma were removed. The remaining packed red blood cells (pRBC) were then washed twice with centrifugation (820 × g for 5 minutes each time) with Dulbecco's phosphate buffer saline (HyClone DPBS; Thermo Scientific). The pRBC pellet was resuspended in HyClone DPBS with 1% (w/v) bovine serum albumin (BSA) (EMD Millipore, Billerica, MA) at a concentration of 2-3 µl pRBC per 200 µl of medium solution. pRBC suspensions were stored at 4°C until use.
Sickle RBC density fractionation
Fractionation of sickle RBCs was performed as described in (1) . Briefly, OptiPrep (Sigma-Aldrich) Density Gradient Medium was used to create a stepwise liquid gradient to separate RBCs based on their respective cell density. PBS was used to adjust the OptiPrep medium density as follows: Density 1: 1.086 g/ml; Density 2: 1.095 g/ml; Density 3: 1.105 g/ml, and Density 4: >1.111 g/ml. The different liquid densities were layered in volumes of 2.5-ml within a 15 ml centrifuge tube, starting with the "Density 4" layer placed at the bottom of the tube. The packed RBCs were washed two times with PBS and centrifuged at 820 × g at 21°C for 5 min. Then the packed RBCs were resuspended in PBS to achieve a 70-80% hematocrit, and layered on top of the least dense layer within the centrifuge tube for centrifugation at 820 × g for 30 min at 21°C. Following centrifugation, the cell populations fractionated between the density layers were isolated carefully. Following the removal of the gradient OptiPrep medium (two washes with PBS), the fractionated cells were resuspended in PBS with 1% BSA where approximately 1 µl of pellet was suspended in 200 µl of PBS-BSA and kept at 4°C until use.
All of the microfluidics tests were conducted within 1-3 days following blood draw. Hematology and hemoglobin electrophoresis results for all samples are summarized in Table S1 .
Device Fabrication
The assembled microfluidic devices comprised a two-layer straight microchannel structure ("flow" and "gas" channels) separated by a free-standing gas-permeable membrane (Fig. S1 ). Each device was fabricated using two different master molds, lithographically patterned with SU-8 negative photoresist (Microchem Corporation, Newton, MA, USA) on a 6-inch silicon wafer. To aid the removal of PDMS from SU-8, all fabricated SU-8 masters were passivated in vacuum for 2 h using fluorosilane vapor: T2492-KG, (tridecafluoro-1,1,2,2-tetrahydrooctyl)-1-trichlorosilane (United Chemical Technologies). Commercial thermocurable PDMS material (Sylgard® 184 silicone elastomer, Dow Corning, Auburn, MI) was used. The prepolymer of PDMS was prepared by mixing the base and the curing agent at a 10:1 weight ratio. Then PDMS prepolymers were either spin-coated (150 µm layer) on the flow-channel SU-8 mold or casted in the gas-channel SU-8 mold ( 5 mm thick) after vacuum degassing. Thermal crosslinking of PDMS films and slabs was performed by curing at 80°C for 2h in both spin-coated and casted masters. Following thermal curing, the inlet and outlet access ports were punched through the gas channel, with diameter of 1.5 mm (Uni-CoreTM punchers, Sigma-Aldrich, St. Louis, MO, USA). Then, the flow channel was aligned to the gas channel in a "cross" configuration to create a rectangular gas-exchange region. The two-layer device was then separated from the SU-8 master and the flow layer ports are punched. Then, the two layer stack was bonded to microscope coverslip substrates using air-plasma treatment (Harrick plasma, PDC-001).
Device Functionalization
We deposited (3-aminopropyl)-trimethoxysilane (APTMS) from the gas-phase for 2 h at room temperature on air-plasma-treated PDMS slabs and microscope coverslips (Harrick plasma, PDC-001). After silanization and bonding, the devices were incubated with FITC-conjugated fibronectin (Cytoskeleton, Denver, CO) in PBS (60 µg/ml) for 1 h at room temperature. The devices were then passivated with a 3% (w/v) BSA (EMD Millipore, Billerica, MA) in PBS solution over night at 4°C and used within 24-48 h. The amount of protein on the microchannel walls was ∼4.5 g/m 2 . FITC fluorescent intensity images of the FN-functionalized channels were acquired using a 10x objective lens to ensure assay reproducibility. Fluorescence intensity was compared using ImageJ (NIH, Bethesda, MD).
Experimental Setup
We designed an in vitro microfluidic platform and implemented a pneumatic pump setup that mimics the in vivo post-capillary venule (∼10-100 µm in diameter) sickle cell adhesion (Fig. S1 ). With the ability to simulate normoxia or hypoxia i.e., low oxygen partial pressure (pO2) conditions, we can simultaneously characterize the isolated effects of sickle RBC adhesive dynamics on functionalized surfaces at a single-cell level.
Sickle RBC adhesive dynamics was observed and quantified in a microfluidic device comprising a free-standing gas-permeable polydimethylsiloxane (PDMS) membrane (∼ 150 µm thick) within a dual-layer microchannel construction. Device design is also described in (2) and is optimized in terms of wall functionalization with fibronectin (FN) to study cell adhesion dynamics. A schematic representation of the microfluidic device is shown in Fig. S1 . The dual-layer device comprises a "flow microchannel" (∼5 -15 µm depth) in which there was flow of an RBC suspension, and a "gas microchannel" (100 µm depth) in which the desired gas mixture was delivered and the oxygen partial pressure regulated. Both flow and gas channels were 3 mm in length and 1.326 mm in width and laid out in a cross configuration. Both flow and gas channels were connected with in-line pressure and flow rate sensors (with feedback loop). This allowed to precisely control the oxygen level of the RBC's microenvironment as well as the wall shear stress within the devices' region of interest (ROI).
The flow channels' rectangular cross section at the ROI has an equivalent hydraulic diameter range of D h ∼ 10 -30 µm. The shear stress near the walls is within the range of τ ∼ 0.035 -0.085 Pa. Within the gas microchannel, pressurized gas is delivered via a high precision pneumatic pump and the O2 concentration is controlled by exchanging gas flow in the channel through the PDMS membrane as follows: Normoxia: O2 concentration ∼20% (vol/vol); Hypoxia: O2 concentration <5%. This platform can deliver rapid deoxygenation to the RBCs in which the O2 concentration decreased from 20 vol% to below 5 vol% within 15 s and maintained at 2 vol% for the rest periods. Transient hypoxia profiles via this platform also explained in detail in (2, 3) .
Furthermore, to enhance the imaging contrast of RBCs i.e., to isolate the information carried by the Hb at 410 nm and 430 nm, a 414/46-nm single-band bandpass filter was used (Semrock). The morphology of the RBCs in hypoxia was visually enhanced, especially in the case of the sickle reticulocyte population the filter greatly helped the visualization of the HbS fiber projections and subsequent retraction of them under reoxygenation.
Lastly, microfluidic device imaging was performed using Zeiss Axiovert 200 and Olympus IX71 inverted microscopes. Hitachi KP-D20A CCD (752p x 582p,) and Olympus DP72 cameras were used for image acquisition. All testing was performed at 37°C using a heating incubator (ibidi heating system, ibidi USA).
Adherent Sickle Cells
Classification. Following the cell classification models of Mohandas (4-7), Kaul (8), Bessis and Bricka (9) and sickle cell specific classification tools developed in-house (10), we categorized adherent sickle cells into the following categories: (I) sickle reticulocytes (SRs), (II) sickle mature erythrocytes (SMEs) of any shape, and (III) irreversibly-sickled cells (ISCs) (Fig. S2) .
SR maturity stages can be further distinguished readily from each other based only on morphological differences: (1) Class 1 sickle reticulocytes (SR1), which are the least mature have a multi-lobular morphology and are relatively motile; and (2) Class 2 more mature sickle reticulocytes (SR2), which are asymmetric "deep dish" morphology, non-motile and feature a highly refractile concentric ring and visible granules (generally one to three in number). The aforementioned classification is identical to the two-stage cell cytological classification for reticulocytes in the rat in (5); where SR1 is the R1 population and SR2 is the R2 population. Regarding the SR1 and the SR2 cell population; the classification criteria in specifying any microscopic classification scheme involves a relative uncertainty or subjectivity of decision. However, as described by Mohandas et al. (5, 6 ) the reproducibility and precision of the unstained, live cell classification scheme appears at least as good as the one obtained by staining.
In-between SRs and SMEs there is an intermediate reticulocyte maturation stage i.e., the R3s; which have not attained the normal discocyte shape yet and generally represent intermediates between SR2s and mature erythrocytes (4). In our adherence classification scheme we include those cells within the SME subpopulation.
SMEs were further classified based on adherence observations under hypoxia. Two categories were generated according to their shape changes compared to their corresponding normoxia-shape as follows: (I) Class I mature sickle erythrocytes (SME1) which exhibit significant morphological shape change under hypoxia (Fig. S2, SME1s , black background). In normoxia these cells are discoid sickle cells and have smooth surface contours similar to the classification of Mohandas (11) (Fig. S2 , SME1s, grey background). Note that in some SME1 image pairs in hypoxia and subsequent reoxygenation there are residual adhesion sites which do not classify as irregular contours. (II) Class II mature sickle cells (SME2) that largely maintain their normoxia-shape in hypoxia (i.e., minimal morphological change) while the cell appears to have irregular surface contours (Fig. S2, SME2s , black background). In normoxia these cells are mostly ellyptocytic sickle cells with already slightly irregular surface contours (Fig. S2 , SME2s, grey background)
ISCs have elongated and elliptocytic morphology in addition to irregular surface contours in normoxia (Fig. S2, ISCs) . Cells classified as "Other" are cells of mostly echinocyte-type and odd-shaped cells that do not fall into any of the previous categories.
Finally, we also classify the unsicklable adherent sickle cells i.e., cells that maintain their normoxia shape throughout our 10 min hypoxic adherence assay.
Statistics. In Fig. S3 cell population statistics are presented. Fig. S3A shows individual non-density-fractionated adherent cell data (% of the total cells per sample) for Patients I, II, III, IV and VIII as identified in Table S1 . Fig. S3B shows bundled non-density-fractionated adherent cell data (% of the total cells per sample) for Patients I, II, III, IV and VIII (Table S1) . Between SME1s and any other cell category the means difference is significant at the P < 0.0001 level, except between SME1s and SME2s where P < 0.001 as indicated in the plot. Fig. S3C shows density-fractionated adherent cell data (% of the total cells) for Patient III (Table S1 ). It is evident that density fraction 2 comprises predominately of SME1 and unsicklable cells (90% of the total combined) whereas in density fraction 4, ISCs and SME2s are mostly adherent (84% of the total combined).
Patient III as well as Patient IV has also been reported in our recent study (1) , in which we measured the normoxic biomechanical properties as a function of cell density via membrane fluctuations (identified as Patients V and XI respectively in that study). In that study, statistically significant data were presented of the increase in the membrane shear modulus and surface to volume increase as the cell density increases, which is correlated with average cell deformability. As a result SME1s exhibit higher average deformability than SME2s.
Simulation Model and Method
We have performed computational studies of cell adhesion dynamics based on dissipative particle dynamics (DPD), a particlebased method for mesoscopic simulations of complex fluid and soft matter systems. In DPD, each particle corresponds to a lump of atoms or molecules, where the particle motion is dictated by a pairwise force that is imposed between the DPD particles. A detailed description and validation of the DPD simulation method of RBCs in capillary and shear flows can be found in (12, 13) .
Cell adhesion dynamics is a complex stochastic process, affected by cell shape, mechanical properties (e.g., elasticity and bending rigidity) and flow conditions (e.g., shear stress). In our previous studies, we have performed detailed computational simulations of cell adhesion dynamics to quantify the biophysical characteristics of malaria-infected RBCs in microcirculation (14, 15) and probe vaso-occlusion phenomena in SCD (16) . Our results revealed that all these factors are important and especially the cell deformability and the strength of the bonds. In the present study, based on the experimental observations, we have documented that there is always a firm adhesion initially at one site, and this is what we impose in our simulations. This model is then used to examine the morphological and mechanical factors involved in cell adhesion dynamics of the sickle mature erythrocytes (SMEs) and the irreversible sickle cells (ISCs) once a strong initial attachment has been already formed (see Figs. 2-3 and Movie S2 and S8).
Sickle cell models. The membrane of SMEs and ISCs is modeled by a triangulated surface with 500 vertices. On the membrane surface, each respective vertex is represented by a DPD particle. The membrane elasticity of cells is imposed by viscoelastic bonds in-between the DPD particles. The cell bending rigidity is modeled by the bending resistance between the triangulated surfaces adjacent to each other. The incompressibility of the lipid bilayer and the cytosol are imposed by area and volume constraints. Sickle cells undergo a morphological transition from a normal biconcave shape to irregular and heterogeneous shapes, e.g. granular, elongated, and crescent (classic sickle) shapes, due to the polymerization of intracellular sickle hemoglobin (HbS) molecules. Due to the fact that it is computationally prohibitive to model polymerization at the molecular level in shear flow, we instead directly model the distortion of RBCs induced by the growing of HbS polymer fibers by applying "effective surface tension" on the cell membrane to transform a normal (AA) discocyte-shaped RBC into a sickle RBC, as we have done in (17) . The shapes that we introduce in the simulations correspond to the shapes that we observe in the videos in the experiment (try to match). In previous work, we have developed a molecular-level mechanistic models to simulate the polymerization and the subsequent growth and branching processes of HbS (18, 19) . We have also developed a kinetic cell sickling model to investigate the cell morphological sickling process under transient hypoxia (3). The kinetic model accounts for cell morphological change, cell sickling delay time, and cell membrane stiffening under transient hypoxia. For details on the sickle RBC models, we refer to refs. (3, 17, 20) .
SMEs of low-density, high-deformability cells and are modeled to have deformable membrane even under hypoxia, consistent with previous findings (21, 22) . Hence, we have modeled the SMEs with membrane mechanical properties similar to those of normal AA-RBCs, i.e., shear modulus µ0= 4.7 pN/µm and bending rigidity k b = 2.4×10 −19 J. For ISCs in normoxia, the cell rigidity can be 2-3 orders of magnitude larger than the normal AA-RBCs (23) . Here, we set the effective shear modulus of ISC to 100µ0.
Adhesion dynamics.
The adhesive interaction between the sickle RBC receptors and the ligand-coated substrate is modeled by the stochastic bond formation/dissociation (24) (25) (26) . At each time step ∆t, when the receptors on the cell membrane are close to ligands on the substrate within a characteristic length don, transient adhesive bonds can be formed with probability Pon = 1 − e −kon∆t , while the existing adhesive bonds can be ruptured with probability P of f = 1 − e −k of f ∆t within a critical length d of f . The bond formation rate kon and the bond dissociation rate k of f are defined by
[1]
where σon and σ of f are the effective formation/rupture strengths. The unstressed reaction rates, k 0 on and k 0 of f are molecular parameters of bond formation and bond dissociation kinetics, also called equilibrium rates or rate constants (27) . For existing bonds, the force between the receptors and ligands is defined by F (l) = 2ks(l − l0), where ks is the spring constant, l is a separation distance between a receptor and a ligand and l0 is the equilibrium length. We note that cell adhesion dynamics is a protein-dependent process, and different receptor-ligand binding exhibits different adhesive characteristics. Even for the same or similar receptor-ligand bonds, bond dissociation kinetics may be regulated by several biophysical factors such as force history, contact duration, and approach velocity (28) (29) (30) . For example, the equilibrium bond dissociation rate, k 0 of f , of the bond of P-selectin (i.e., cell adhesion molecule on the surface of activated endothelial cells) and its primary ligand: the P-selectin glycoprotein ligand 1 (PSGL-1), is in the range of 10 −2 -10 1 s −1 at different unbinding force measurements obtained by using atomic force microscopy(AFM) (28) (29) (30) (31) . In this work, we chose a set of adhesive parameters for both SME and ISC models (14, 16, 25, (31) (32) (33) presented in Table S2 . Sensitivity analysis. We have performed extensive sensitivity studies for the adhesion dynamics of sickle cells by changing the equilibrium bond formation rate, k 0 on . In Fig. 3C we model granular-shaped SMEs, whereas in Fig. S4A we model discoid-shaped SMEs. In both figures the modeled SMEs exhibit increasing numbers of adhesion binding sites with increasing bond formation rate k 0 on . As shown in Fig. S4A , discoid SMEs have increasing number of adhesion sites with increasing bond formation rate, which is similar to the adhesion dynamics of granular SMEs (Fig 3C) . In Fig. S4B we compare modeled granular, discoid and elongated SME shapes at different values of the bond formation rate (0.1-10 k 0 on ), while the cell-wall contact area is comparable in all modeled shapes. We observe that the number of adhesion sites per cell is less dependent on the cell shape, but it correlates rather strongly with increasing reaction rate, see Fig. S4B . Since the contact area of varying SME shapes is comparable, bond formation rate becomes a dominant factor in their adhesive dynamics. For ISCs, however, the number of adhesion sites fluctuates between 1 and 2 when the equilibrium bond formation rate is within the range of 0.1-10 k 0 on , indicating that it is more difficult for the ISCs to form adhesive binding sites (16) . Fig. S1 . Cross-sectional schematic representation of the sickle cell adhesive dynamics microfluidic device: The dual-layer design consists of a "flow channel" i.e., flow of RBC suspension and a "gas channel" for gas mixture and pressure regulation. Representative RBC adherent cell (in red) under a microscopes' objective lens field of view. Gas-permeable PDMS membrane in blue. FN-functionalized surfaces in green. Precise liquid flow profile can be delivered through a pressure differential from the "cell inlet and outlet". (Schematic not in scale). Table S1 ). (B) Non-fractionated cell density data. Box plot of adherent cells (% of the total cells per sample) for Patients I, II, III, IV and VIII (Table S1 ). Standard analysis of variance tests were used to determine the significance of the means difference between the adherent cell categories, where ***P < 0.001. Horizontal lines within the boxes represent the mean value within the distribution, whereas the vertical bars represent the Min and Max values. (C) Density-fractionated cell data. Adherent cells (% of the total cells per sample) for Patient III (Table S1 ) 
